✦ LIBER ✦

Aluminium in Alzheimer’s disease: are we still at a crossroad?

✍ Scribed by Veer Bala Gupta; S. Anitha; M. L. Hegde; L. Zecca; R. M. Garruto; R. Ravid; S. K. Shankar; R. Stein; P. Shanmugavelu; K. S. Jagannatha Rao

Publisher: Springer
Year: 2005
Tongue: English
Weight: 317 KB
Volume: 62
Category: Article
ISSN: 1420-682X
DOI: 10.1007/s00018-004-4317-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSP at a crossroads: The first solar ele

CSP at a crossroads: The first solar electric power plants are still proving their worth after three decades, so why aren't we seeing more CSP reach the development stage?

✍ Andy Skumanich 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 985 KB

How useful are cholinesterase inhibitors

How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis

✍ Gill Livingston; Cornelius Katona 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Objectives. To report on a Numbers Needed to Treat (NNT) analysis of the literature identi®ed through a systematic review of trials of cholinesterase inhibitors in Alzheimer's Disease. Design. Search of Medline (1966±1998), EMBASE (1994±1999) and Psychlit (1974±1998) using the keywords cholinestera

The neuroprotective effects of Cerebroly

The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance

✍ E. Rockenstein; A. Adame; M. Mante; H. Moessler; M. Windisch; E. Masliah 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 552 KB

Gene Expression Alterations in the Sphin

Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?

✍ Pavel Katsel; Celeste Li; Vahram Haroutunian 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract Activating the ERK pathway (extracellular signal‐regulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views